Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Amortization of Deferred Charges (2018 - 2024)

Historic Amortization of Deferred Charges for ImmunoTech (AIM) over the last 4 years, with Q4 2024 value amounting to $69000.0.

  • ImmunoTech's Amortization of Deferred Charges changed N/A to $69000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $301000.0, marking a year-over-year change of. This contributed to the annual value of $301000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, ImmunoTech's Amortization of Deferred Charges is $69000.0.
  • In the past 5 years, ImmunoTech's Amortization of Deferred Charges registered a high of $197000.0 during Q2 2024, and its lowest value of -$139000.0 during Q2 2020.